DRUG DELIVERY SYSTEM COMPRISING A TETRAHIDROXILATED ESTROGEN FOR USE IN HORMONAL CONTRACEPTION

Details for Australian Patent Application No. 2002311676 (hide)

Owner PANTARHEI BIOSCIENCE B.V.

Inventors BUNSCHOTEN, Evert, Johannes; HOLINKA, Christian, Franz; COELINGH BENNINK, Herman, Jan, Tijmen

Pub. Number AU-A-2002311676

PCT Number PCT/NL02/00331

PCT Pub. Number WO2002/094279

Priority 01201945.1 23.05.01 EP; 01201947.7 23.05.01 EP; 01204377.4 15.11.01 EP; 02075695.3 21.02.02 EP; 01201946.9 23.05.01 EP

Filing date 23 May 2002

Wipo publication date 3 December 2002

International Classifications

A61K 031/567 - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 031/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 015/18 Drugs for genital or sexual disorders

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 01201945.1 23.05.01 EP; 01201947.7 23.05.01 EP; 01204377.4 15.11.01 EP; 02075695.3 21.02.02 EP; 01201946.9 23.05.01 EP

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002311676

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002311677-USE OF ESTROGENIC COMPOUNDS IN COMBINATION WITH PROGESTOGENIC COMPOUNDS IN HORMONEREPLACEMENT THERAPY

2002311675-DRUG DELIVERY SYSTEM COMPRISING A TETRAHYDROXYLATED ESTROGEN FOR USE IN HORMONAL CONTRACEPTION